苯肼,硫酸盐结构式
|
常用名 | 苯肼,硫酸盐 | 英文名 | Phenelzine (sulfate) |
|---|---|---|---|---|
| CAS号 | 156-51-4 | 分子量 | 234.27300 | |
| 密度 | N/A | 沸点 | 497.4ºC at 760 mmHg | |
| 分子式 | C8H14N2O4S | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 254.6ºC | |
| 符号 |
GHS06 |
信号词 | Danger |
苯肼,硫酸盐用途Phenelzine硫酸盐是一种非选择性和不可逆的单胺氧化酶抑制剂 (MAOI), 用作抗抑郁药和抗焦虑药。 |
| 中文名 | 苯肼,硫酸盐 |
|---|---|
| 英文名 | Phenelzine hydrogen sulphate |
| 中文别名 | 硫酸苯乙肼 |
| 英文别名 | 更多 |
| 沸点 | 497.4ºC at 760 mmHg |
|---|---|
| 分子式 | C8H14N2O4S |
| 分子量 | 234.27300 |
| 闪点 | 254.6ºC |
| 精确质量 | 234.06700 |
| PSA | 121.03000 |
| LogP | 2.21160 |
| 蒸汽压 | 1.04E-10mmHg at 25°C |
| 储存条件 | 2-8℃ |
| 水溶解性 | Freely soluble in water; practically insoluble in ethanol (96%) and in ether . |
| 计算化学 | 1.疏水参数计算参考值（XlogP）:无 2.氢键供体数量:4 3.氢键受体数量:6 4.可旋转化学键数量:3 5.互变异构体数量:无 6.拓扑分子极性表面积121 7.重原子数量:15 8.表面电荷:0 9.复杂度:159 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:2 |
| 更多 | 1.熔点（ºC）：166.5~171 |
| 符号 |
GHS06 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H301 |
| 警示性声明 | Missing Phrase - N15.00950417 |
| 个人防护装备 | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| 危害码 (欧洲) | Xn |
| 风险声明 (欧洲) | R22 |
| 危险品运输编码 | UN 2811 6.1/PG 3 |
| WGK德国 | 3 |
| RTECS号 | MV8750000 |
| 包装等级 | III |
| 危险类别 | 6.1(b) |
| 海关编码 | 2928000090 |
| 海关编码 | 2928000090 |
|---|---|
| 中文概述 | 2928000090 其他肼（联氨）及胲（羟胺）的有机衍生物。监管条件:无。增值税率:17.0%。退税率:9.0%。最惠国关税:6.5%。普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2928000090 other organic derivatives of hydrazine or of hydroxylamine VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |
|
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
Biol. Psychiatry 34(6) , 1467-81, (2009) Previous work has shown that repeated desipramine treatment causes downregulation of the norepinephrine transporter (NET) and persistent antidepressant-like effects on behavior, ie effects observed 2 ... |
|
|
Monoamine oxidase inhibitors revisited: what you should know.
J. Clin. Psychiatry 74(2) , 189-91, (2013)
|
|
|
Potential repurposing of known drugs as potent bacterial β-glucuronidase inhibitors.
J. Biomol. Screen. 17(7) , 957-65, (2012) The active metabolite of the chemotherapeutic irinotecan, SN-38, is detoxified through glucuronidation and then excreted into the gastrointestinal tract. Intestinal bacteria convert the glucuronidated... |
| EINECS 205-856-0 |
| 2-phenylethylhydrazine,sulfuric acid |
| Phenelzine sulfate salt |
| Phenelzine Sulfate |
| PHENETHYLHYDRAZINE SULFATE |
| MFCD00050687 |
| Phenelzine (sulfate) |
查看所有供应商和价格请点击：